Our leadership
We are a passionate team driven by our shared mission of making a significant positive impact on the treatment of childhood cancers. We are building an international consortium made up of drug discovery and development experts, clinical specialists, funders, impact investors and others to advance innovative science into effective and well tolerated therapies.
Joint Management Team
Our Joint Management Team brings together leaders from Cancer Research Horizons and LifeArc to oversee delivery of our shared strategy. The team offers expertise across the full translational process. This includes drug discovery, scientific delivery, business development, and sourcing strategy. They also leverage their expertise in programme management, patient engagement, and communications to increase our overall impact.
James Pickett
Co-lead
Cancer Research Horizons
Lone Friis
Co-lead
LifeArc
Itziar Areso
Diligence
LifeArc
Curtis Asante
Programme Management
LifeArc
Marta Barisa
Sourcing
Cancer Research Horizons
Caroline Barton
Science Delivery
LifeArc
Kevin Buchan
Partnering
LifeArc
Thomas Edwards
Partnering
Cancer Research Horizons
Kate Harris
Programme Management
Cancer Research Horizons
Neil Jones
Science Delivery
Cancer Research Horizons
Sheena Patel
Diligence
Cancer Research Horizons
Pierre Peotta
Marketing & Communications
Cancer Research Horizons
Natasha Ratcliffe
Patient Engagement
LifeArc
Victoria Walker
Patient Engagement
Cancer Research UK
Joint Steering Committee
The Joint Steering Committee approves the sourcing strategy for potential projects, reviews proposed project applications, approves the inclusion of proposed projects into the consortium, oversees the progress of projects, the consortium’s budget and the consortium’s intellectual property, among other responsibilities. The group is made up of members from the core partners, Cancer Research Horizons, LifeArc and Great Ormond Street Hospital Charity (GOSH Charity).
Tony Hickson
Executive leadership / Chief Business Officer
C-Further / Cancer Research Horizons
Alex Bonner
Head of Grant Funding
GOSH Charity
Iain Foulkes
Chief Executive Officer | Executive Director of Research and Innovation
Cancer Research Horizons | Cancer Research UK
Wendy Jacquemet-Ross
Head of Partnerships, Childhood Cancer
LifeArc
George Orphanides
Chief Scientific Officer
LifeArc
Aoife Regan
Director of Charitable Programmes and Impact
GOSH Charity
Hamish Ryder
CEO, Therapeutic Innovation
Cancer Research Horizons
Nicola Wallis
Head of Therapeutics Platforms
LifeArc
Scientific Advisory Board
Our scientific advisory board provides independent scientific review for new and active consortium projects and portfolio review as well as advises on areas of overall strategy for the consortium. The scientific advisory board is made up of leaders representing a broad range of scientific expertise, including but not limited to, childhood cancer biology, therapeutic discovery, clinical development and unmet need, and the regulatory and commercial landscape.
Alison Maloney
Chair
Dark Blue Therapeutics
Samuel C. Blackman
Member
Google Ventures
Frank Mussai
Member
Roche/Birmingham Children’s Hospital
Andy Pearson
Member
Childhood cancer consultant
Sarah Tasian
Member
Children's Hospital of Philadelphia